Research Paper Volume 13, Issue 23 pp 25072—25088

Construction and validation of a metabolic gene-associated prognostic model for cervical carcinoma and the role on tumor microenvironment and immunity


Figure 5. Cox regression and Kaplan-Meier survival analysis of risk score and clinicopathological parameters. (A) Cox regression analysis of risk score and clinicopathological parameters, which indicate the MPGM could as an independent prognostic factor. (B) Patients stratified by ages (age ≤ 65 and > 65), (C) Patients stratified by stage (stage I-II and stage III/IV), (D) Patients stratified by T stage (T1-2 and T3-4), (E) Patients stratified by M stage (M0 and M1) and (F) Patients stratified by N stage (N0 and N1).